Skip to main content
SpringerLink
Log in

Pertuzumab-associated AEs: disproportionality analysis of FAERS data

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Zou S, et al. A disproportionality analysis of adverse events associated to pertuzumab in the FDA Adverse Event Reporting System (FAERS). BMC Pharmacology & Toxicology : 13 Nov 2023. Available from: URL: https://doi.org/10.1186/s40360-023-00702-w

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pertuzumab-associated AEs: disproportionality analysis of FAERS data. Reactions Weekly 1984, 9 (2023). https://doi.org/10.1007/s40278-023-50240-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-023-50240-x

Search

Navigation